Literature DB >> 11317524

Invasion and metastasis: the expression and significance of matrix metalloproteinases in carcinomas of the lung.

B Bodey1, B Bodey1, A M Gröger, S E Siegel, H E Kaiser.   

Abstract

Structural changes in the extracellular matrix (ECM) are necessary for cell migration during tissue remodeling and tumor invasion. The matrix metalloproteinases (MMPs) and their inhibitors have been shown to be critical modulators of ECM composition and are thus, crucial in neoplastic cell invasion and metastasis. Expression of MMP-2, -3, -9, -10, and -13 was investigated in human lung adenocarcinomas employing an indirect alkaline phosphatase conjugated immunocytochemical technique. Evaluation of the results was based on (a) the percent of neoplastically transformed cells/surrounding stroma that reacted positively and (b) a measure of staining intensity [graded from A (highest) to D]. The two forms of stromelysin, MMP-3 and -10, share 82% sequence homology, but exhibit differences in cellular synthesis and inducibility by cytokines and growth factors in vitro. Strong overall expression of MMP-3 and -10 was found in lung adenocarcinomas, especially in the ECM adjacent to blood vessels. Positive immunoreactivity could be seen for these two MMPs in the ECM surrounding over 90% of the neoplastically transformed cells (++++), and the staining intensity was also the strongest possible (A,B). Focal (+), high intensity (A,B) staining could be detected for MMP-2, -9, and -13. Thus, it seems that the stromelysins are involved in the generalized growth and expansion of the neoplastic cell mass, while MMP-2, -9 and -13 are involved in the neoangiogenic and focal clonal selection and expansion phenomena associated with in situ tumor progression, invasion of the microvasculature, and metastasis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11317524

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  16 in total

1.  MMP-10 is overexpressed, proteolytically active, and a potential target for therapeutic intervention in human lung carcinomas.

Authors:  Jason H Gill; Ian G Kirwan; Jill M Seargent; Sandie W Martin; Sidiq Tijani; Vladimir A Anikin; Alan J Mearns; Michael C Bibby; Alan Anthoney; Paul M Loadman
Journal:  Neoplasia       Date:  2004 Nov-Dec       Impact factor: 5.715

2.  Matrix metalloproteinases production in malignant pleural effusions after talc pleurodesis.

Authors:  P D'Agostino; A Rao Camemi; R Caruso; F Arcoleo; A Cascio; A Dolce; E Sacco; G Cangemi; T di Rosa; P Moceo; E Cillari
Journal:  Clin Exp Immunol       Date:  2003-10       Impact factor: 4.330

3.  Angiogenesis and progression in human melanoma.

Authors:  R Ria; A Reale; A Castrovilli; G Mangialardi; F Dammacco; D Ribatti; A Vacca
Journal:  Dermatol Res Pract       Date:  2010-06-06

Review 4.  Meta-analysis of association of the matrix metalloproteinase 2 (-735 C/T) polymorphism with cancer risk.

Authors:  Su Kang Kim; Sang Wook Kang; Hae Jeong Park; Ju Yeon Ban; Chung-Hun Oh; Joo-Ho Chung; In-Hwan Oh; Kyu Bong Cho; Min-Su Park
Journal:  Int J Clin Exp Med       Date:  2015-10-15

5.  Matrix metalloproteinase-10 is a critical effector of protein kinase Ciota-Par6alpha-mediated lung cancer.

Authors:  L A Frederick; J A Matthews; L Jamieson; V Justilien; E A Thompson; D C Radisky; A P Fields
Journal:  Oncogene       Date:  2008-04-21       Impact factor: 9.867

6.  The IGF-I receptor can alter the matrix metalloproteinase repertoire of tumor cells through transcriptional regulation of PKC-{alpha}.

Authors:  Shun Li; Donglei Zhang; Long Yang; Julia V Burnier; Ni Wang; Rongtuan Lin; Eunice R Lee; Robert I Glazer; Pnina Brodt
Journal:  Mol Endocrinol       Date:  2009-10-23

7.  Gene expression analysis in Interleukin-12-induced suppression of mouse mammary carcinoma.

Authors:  Xiaoyan Shi; Jianguo Liu; Zhaoying Xiang; Maki Mitsuhashi; Rita S Wu; Xiaojing Ma
Journal:  Int J Cancer       Date:  2004-07-01       Impact factor: 7.396

Review 8.  Angiogenesis in melanoma.

Authors:  Ganapati H Mahabeleshwar; Tatiana V Byzova
Journal:  Semin Oncol       Date:  2007-12       Impact factor: 4.929

9.  Genome-wide analysis of molecular changes in IL-12-induced control of mammary carcinoma via IFN-gamma-independent mechanisms.

Authors:  Xiaoyan Shi; Shanjin Cao; Maki Mitsuhashi; Zhaoying Xiang; Xiaojing Ma
Journal:  J Immunol       Date:  2004-04-01       Impact factor: 5.422

10.  Genetic polymorphisms in MMP 2, 9 and 3 genes modify lung cancer risk and survival.

Authors:  Patricia González-Arriaga; Teresa Pascual; Arturo García-Alvarez; Ana Fernández-Somoano; M Felicitas López-Cima; Adonina Tardón
Journal:  BMC Cancer       Date:  2012-03-28       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.